SPIA
DAWN

Steward Partners Investment Advisory’s Day One Biopharmaceuticals DAWN Stock Holding History

Steward Partners Investment Advisory’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-300
Closed -$2.12K – 4351
2025
Q3 		$2.12K Hold
300
– – ﹤0.01% 3908
2025
Q2 		$1.95K Hold
300
– – ﹤0.01% 3739
2025
Q1 		$2.38K Buy
+300
New +$3.23K ﹤0.01% 3607

Other funds holding DAWN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Steward Partners Investment Advisory's DAWN Position: Q4 2025 in Review

Steward Partners Investment Advisory sold out of Day One Biopharmaceuticals (DAWN) in Q4 2025, closing a stake of 300 shares — an estimated $2.12K sold.

Steward Partners Investment Advisory first reported a position in DAWN in Q1 2025 and held it in 3 quarters. The position peaked at $2.38K in Q1 2025. 183 funds tracked by Wall St. Rank hold DAWN as of Q4 2025.

  • Steward Partners Investment Advisory reported no remaining Day One Biopharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 300 Day One Biopharmaceuticals shares in Q4 2025, an estimated $2.12K.
  • Steward Partners Investment Advisory first reported a position in Day One Biopharmaceuticals in Q1 2025 and held it in 3 quarters.
  • Steward Partners Investment Advisory's Day One Biopharmaceuticals position peaked at $2.38K in Q1 2025.
  • 183 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q4 2025.

Based on Steward Partners Investment Advisory's 13F filing for Q4 2025, filed 12 Feb 2026.